FIVE PRIME THERAPEUTICS INC - COM (FPRX)

CUSIP: 33830X104

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM
Total 13F shares
38,992,067
Share change
+11,988,729
Total reported value
$663,730,930
Put/Call ratio
81%
Price per share
$17.01
Number of holders
120
Value change
+$229,009,443
Number of buys
90
Number of sells
45

Quarterly Holders Quick Answers

What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q4 2020

As of 31 Dec 2020, FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by 120 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 38,992,067 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., RTW INVESTMENTS, LP, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, Invesco Ltd., First Light Asset Management, LLC, DIMENSIONAL FUND ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, and RENAISSANCE TECHNOLOGIES LLC. This page lists 120 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.